FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2570331431> ?p ?o ?g. }

• W2570331431 endingPage "226" @default.
• W2570331431 startingPage "221" @default.
• W2570331431 abstract "Abstract About a third of all human cancers harbor mutations in one of the K-, N-, or HRAS genes that encode an abnormal RAS protein locked in a constitutively activated state to drive malignant transformation and tumor growth. Despite more than three decades of intensive research aimed at the discovery of RAS-directed therapeutics, there are no FDA-approved drugs that are broadly effective against RAS-driven cancers. Although RAS proteins are often said to be “undruggable,” there is mounting evidence suggesting it may be feasible to develop direct inhibitors of RAS proteins. Here, we review this evidence with a focus on compounds capable of inhibiting the interaction of RAS proteins with their effectors that transduce the signals of RAS and that drive and sustain malignant transformation and tumor growth. These reports of direct-acting RAS inhibitors provide valuable insight for further discovery and development of clinical candidates for RAS-driven cancers involving mutations in RAS genes or otherwise activated RAS proteins. Cancer Res; 77(2); 221–6. ©2017 AACR." @default.
• W2570331431 created "2017-01-13" @default.
• W2570331431 creator A5034358215 @default.
• W2570331431 creator A5041496852 @default.
• W2570331431 creator A5071802884 @default.
• W2570331431 date "2017-01-15" @default.
• W2570331431 modified "2023-10-12" @default.
• W2570331431 title "The RAS–Effector Interaction as a Drug Target" @default.
• W2570331431 cites W1781950500 @default.
• W2570331431 cites W1964930474 @default.
• W2570331431 cites W1965532315 @default.
• W2570331431 cites W1992450378 @default.
• W2570331431 cites W2000297746 @default.
• W2570331431 cites W2001400574 @default.
• W2570331431 cites W2004429286 @default.
• W2570331431 cites W2012479646 @default.
• W2570331431 cites W2025499369 @default.
• W2570331431 cites W2026808860 @default.
• W2570331431 cites W2043282329 @default.
• W2570331431 cites W2067900518 @default.
• W2570331431 cites W2074299686 @default.
• W2570331431 cites W2075039358 @default.
• W2570331431 cites W2080719056 @default.
• W2570331431 cites W2081990599 @default.
• W2570331431 cites W2085736853 @default.
• W2570331431 cites W2087347929 @default.
• W2570331431 cites W2092973995 @default.
• W2570331431 cites W2093323373 @default.
• W2570331431 cites W2096294661 @default.
• W2570331431 cites W2097863579 @default.
• W2570331431 cites W2098760239 @default.
• W2570331431 cites W2107786992 @default.
• W2570331431 cites W2109031404 @default.
• W2570331431 cites W2112078762 @default.
• W2570331431 cites W2114138419 @default.
• W2570331431 cites W2121951430 @default.
• W2570331431 cites W2128339707 @default.
• W2570331431 cites W2130182381 @default.
• W2570331431 cites W2131037662 @default.
• W2570331431 cites W2141965353 @default.
• W2570331431 cites W2144535642 @default.
• W2570331431 cites W2147687412 @default.
• W2570331431 cites W2148309992 @default.
• W2570331431 cites W2254753782 @default.
• W2570331431 cites W2339828620 @default.
• W2570331431 doi "https://doi.org/10.1158/0008-5472.can-16-0938" @default.
• W2570331431 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5243175" @default.
• W2570331431 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28062402" @default.
• W2570331431 hasPublicationYear "2017" @default.
• W2570331431 type Work @default.
• W2570331431 sameAs 2570331431 @default.
• W2570331431 citedByCount "58" @default.
• W2570331431 countsByYear W25703314312017 @default.
• W2570331431 countsByYear W25703314312018 @default.
• W2570331431 countsByYear W25703314312019 @default.
• W2570331431 countsByYear W25703314312020 @default.
• W2570331431 countsByYear W25703314312021 @default.
• W2570331431 countsByYear W25703314312022 @default.
• W2570331431 countsByYear W25703314312023 @default.
• W2570331431 crossrefType "journal-article" @default.
• W2570331431 hasAuthorship W2570331431A5034358215 @default.
• W2570331431 hasAuthorship W2570331431A5041496852 @default.
• W2570331431 hasAuthorship W2570331431A5071802884 @default.
• W2570331431 hasBestOaLocation W25703314311 @default.
• W2570331431 hasConcept C104317684 @default.
• W2570331431 hasConcept C1167327 @default.
• W2570331431 hasConcept C121608353 @default.
• W2570331431 hasConcept C127812441 @default.
• W2570331431 hasConcept C203014093 @default.
• W2570331431 hasConcept C2781187634 @default.
• W2570331431 hasConcept C501734568 @default.
• W2570331431 hasConcept C502942594 @default.
• W2570331431 hasConcept C51785407 @default.
• W2570331431 hasConcept C54355233 @default.
• W2570331431 hasConcept C57074206 @default.
• W2570331431 hasConcept C60644358 @default.
• W2570331431 hasConcept C62478195 @default.
• W2570331431 hasConcept C70721500 @default.
• W2570331431 hasConcept C74187038 @default.
• W2570331431 hasConcept C86803240 @default.
• W2570331431 hasConceptScore W2570331431C104317684 @default.
• W2570331431 hasConceptScore W2570331431C1167327 @default.
• W2570331431 hasConceptScore W2570331431C121608353 @default.
• W2570331431 hasConceptScore W2570331431C127812441 @default.
• W2570331431 hasConceptScore W2570331431C203014093 @default.
• W2570331431 hasConceptScore W2570331431C2781187634 @default.
• W2570331431 hasConceptScore W2570331431C501734568 @default.
• W2570331431 hasConceptScore W2570331431C502942594 @default.
• W2570331431 hasConceptScore W2570331431C51785407 @default.
• W2570331431 hasConceptScore W2570331431C54355233 @default.
• W2570331431 hasConceptScore W2570331431C57074206 @default.
• W2570331431 hasConceptScore W2570331431C60644358 @default.
• W2570331431 hasConceptScore W2570331431C62478195 @default.
• W2570331431 hasConceptScore W2570331431C70721500 @default.
• W2570331431 hasConceptScore W2570331431C74187038 @default.
• W2570331431 hasConceptScore W2570331431C86803240 @default.
• W2570331431 hasFunder F4320332161 @default.
• W2570331431 hasIssue "2" @default.

• next